Prostate Cancer - Results from #1640

Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC). December 21, 2023

Performance of cognitive vs. image-guided fusion biopsy for detection of overall and clinically significant prostate cancer in a multiethnic population. December 21, 2023

Based on PI-RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4-20 ng/mL. December 21, 2023

RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate Cancer. December 21, 2023

PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer. December 21, 2023

Citron Kinase Is a Druggable Target in Treatment-Resistant Prostate Cancer. December 21, 2023

Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer. December 21, 2023

Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells. December 21, 2023

Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study. December 20, 2023

Pain and its association with survival for Black and White individuals with advanced prostate cancer in the US. December 20, 2023

Retzius-Sparing Robotic-Assisted Prostatectomy: Technical Challenges for Surgeons and Key Prospective Refinements. December 20, 2023

A transparent synthetic peptide hydrogel as a haemostatic agent in athermal nerve sparing robot-assisted radical prostatectomy: an observational study. December 20, 2023

Risk of Biochemical Recurrence in Patients with Grade Group 1 Prostate Cancer with Extraprostatic Extension Treated with Radical Prostatectomy. December 20, 2023

Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective-Prospective [68Ga]Ga-PSMA-11 PET/CT Study. December 20, 2023

Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironment. December 20, 2023

Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer. December 20, 2023

Impact of COVID-19 pandemic on ambulatory urologic oncology surgeries. December 19, 2023

MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing. December 19, 2023

A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer. December 19, 2023

Health-related quality of life among prostate cancer survivors with metastatic disease and non-metastatic disease and men without a cancer history in the USA. December 19, 2023

Page 83 of 1436